In-home Decluttering Augmentation of Group CBT for HD

Sponsor
Karolinska Institutet (Other)
Overall Status
Recruiting
CT.gov ID
NCT04712474
Collaborator
Region Stockholm (Other), City of Stockholm (Other), Swedish Council for Working Life and Social Research (Other)
90
1
2
47.5
1.9

Study Details

Study Description

Brief Summary

The primary aim of trial is to determine the clinical efficacy of in-home decluttering augmentation of group CBT for reducing hoarding severity in adults with HD. The trial takes place in Sweden.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: In-home decluttering practice
N/A

Detailed Description

Cognitive behavioral therapy (CBT) is the current evidence-based treatment for HD but the majority of sufferers remain symptomatic after CBT with impairing levels of clutter in their homes. Home visits, with a focus on in-home decluttering, have in previous research been shown to be a promising intervention when combined with CBT. However, augmenting CBT with subsequent home visits has not yet been tested in a randomized controlled trial (RCT). In response to this, in this trial, we aim to investigate the efficacy of a coordinated intervention, consisting of CBT and in-home decluttering for HD, in an RCT. In this trial, 90 participants with HD will initially receive 12 sessions of CBT through a psychiatric outpatient service. After CBT, participants will be randomized to receive either 10 home visits in 10 weeks, or to a wait list condition. Our hypothesis is that augmenting CBT with home visits will lead to a reduction in hoarding symptoms and clutter and improved daily functioning compared to wait list. We will also investigate the cost-economical aspects of the intervention. Results from this trial have the potential to reveal whether in-home decluttering should be added to CBT in order to reduce symptoms of hoarding and improve function in indviduals with HD.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
In-home Decluttering Augmentation of Group Cognitive-behavior Therapy for Hoarding Disorder: The Joining Forces Randomized Controlled Trial
Actual Study Start Date :
Jan 29, 2021
Anticipated Primary Completion Date :
Jun 30, 2023
Anticipated Study Completion Date :
Jan 15, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: In-home decluttering

Study participants receive weekly sessions of in-home decluttering for 10 weeks.

Behavioral: In-home decluttering practice
The in-home decluttering intervention comprises 10, 1.5-hour home-visits over the course of 10 weeks. These home visits are personalized, goal-oriented and focused on decluttering. They include 1) a brief check-in, 2) guided unclutter time 3) a reflective period during which participants share their thoughts and objectives for the coming week, and 4) homework assignments.

No Intervention: Delayed treatment

Study participants receive weekly session of in-home decluttering after a 10 week delay.

Outcome Measures

Primary Outcome Measures

  1. Saving Inventory-Revised (SI-R) [Change from baseline (week 0) to post-treatment (week 10),]

    The SI-R is a 23-item questionnaire with 3 sub-scales: 1) difficulty discarding, 2) excessive clutter, and 3) excessive acquisition.

  2. Clutter Image Rating Scale (CIR) [Change from baseline (week 0) to post-treatment (week 10).]

    Three sets of photographs, each comprising 9 photos of a room with varying levels of clutter. A selection is made as to which photograph best resembles the room of the participant.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. Age 18 years or older.

  2. Hoarding disorder as primary psychiatric condition.

  3. Willing and able to understand and complete consent and study procedures.

  4. Living in the Stockholm county (Sweden) and within a 1-hour commute by public transport from the social services office.

Exclusion Criteria:
  1. Concurrent CBT or having received CBT for HD during the last two years, for a minimum of 8 sessions including active strategies for reducing acquisition and practice of discarding with a qualified therapist or 8 previous in-home decluttering sessions with a qualified social worker.

  2. Unable or unwilling to allow study staff into home for home assessment.

  3. Animal hoarding or squalid (i.e. extremely unhygienic) home conditions that are deemed to put the personnel at risk during the in-home decluttering.

  4. A diagnosis of organic brain disorder, intellectual disability, psychosis, bipolar disorder without stable medication or with symptoms within the last 6 months, anorexia nervosa or alcohol/substance dependence or abuse.

  5. Major medical or neurological conditions that increase the risk of participation or that would prevent completing assigned behavioral practice tasks.

  6. Immediate risk to self or others, requiring urgent medical attention, such as high suicidality risk.

  7. Participant not able to read and communicate in Swedish.

  8. Currently at high risk for eviction (for instance having received a "rättelseanmaning" by the housing company or Swedish court).

  9. Potential participant lives in the same household as an already included participant.

Contacts and Locations

Locations

Site City State Country Postal Code
1 M46: Karolinska Universitetssjukhuset, Psykiatri Sydväst Stockholm, Huddinge, Sweden, 141 86 Stockholm Sweden 141 86

Sponsors and Collaborators

  • Karolinska Institutet
  • Region Stockholm
  • City of Stockholm
  • Swedish Council for Working Life and Social Research

Investigators

  • Principal Investigator: Volen Ivanov, PhD, Karolinska Institutet

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Volen Ivanov, Principal Investigator, Karolinska Institutet
ClinicalTrials.gov Identifier:
NCT04712474
Other Study ID Numbers:
  • 2020-05798
First Posted:
Jan 15, 2021
Last Update Posted:
Sep 22, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Volen Ivanov, Principal Investigator, Karolinska Institutet
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 22, 2021